際際滷

際際滷Share a Scribd company logo

Treatment of Diabetic Retinopathy.pptx

Download as PPTX, PDF
G
Golam Mortuza

Diabetes is a major concern throughout the world. The prevalence of diabetes as well as the number of the diabetic retinopathy are relentlessly increasing. Diabetic Macular Oedema (DMO) is one of the commonest cause of visual loss in recent years. In today's topic we'll be discussing about treatment of diabetic retinopaty in a concise form.

1 of 7
Download to read offline
TREATMENT OF DIABETIC RETINOPATHY By Dr. Golam Mortuza
Management of Diabetes Drugs for DM: Oral hypoglycaemic drugs Insulin injections Other cares: Diet and Exercise Risk reduction: Rx of Hypertension and Hyperlipidemia R/O Anaemia and Renal failure Quit smoking and tobacco in any form
Centre involved DMO or CSMO: Phakic Eye Pseudophakic eye Anti-VEGF Contraindicated (Pregnancy, Recent MI) Intravitreal Anti- VEGF:VA6/15:- Aflibercept VA>6/15:- Aflibercept,Ranibizumab or Bevacizumab Intravitreal Triamcenolone Intravitreal Triamcenolone Note: Intravitreal Triamcenolone might cause cataract in phakic eye. Laser or Intravitreal Triamcenolone may be tried after 6 injections of Anti- VEGF (given monthly) if these fail to reduce CSMO
Off Centre DMO (outside 500亮 from foveola): Focal or Grid laser Note: Intravitreal Anti-VEGF or Triamcinolone may be tried if it fails to reduce oedema
DMO with PDR: Inj Ranibizumab or Aflibercept followed by PRP. Note: PRP is done in 2-3 sittings to get rid of exerbation of macular oedema.
PDR without DMO: PRP in 2-3 sittings Note: Alternatively Inj Ranibizumab or Aflibercept may be given. Inj Bevacizumab is not that effective.
Indications of Surgery in Diabetic Retinopaty: Resistant cases, particularly if VMT or ERM is present ADED

More Related Content

Treatment of Diabetic Retinopathy.pptx

  • 2. Management of Diabetes Drugs for DM: Oral hypoglycaemic drugs Insulin injections Other cares: Diet and Exercise Risk reduction: Rx of Hypertension and Hyperlipidemia R/O Anaemia and Renal failure Quit smoking and tobacco in any form
  • 3. Centre involved DMO or CSMO: Phakic Eye Pseudophakic eye Anti-VEGF Contraindicated (Pregnancy, Recent MI) Intravitreal Anti- VEGF:VA6/15:- Aflibercept VA>6/15:- Aflibercept,Ranibizumab or Bevacizumab Intravitreal Triamcenolone Intravitreal Triamcenolone Note: Intravitreal Triamcenolone might cause cataract in phakic eye. Laser or Intravitreal Triamcenolone may be tried after 6 injections of Anti- VEGF (given monthly) if these fail to reduce CSMO
  • 4. Off Centre DMO (outside 500亮 from foveola): Focal or Grid laser Note: Intravitreal Anti-VEGF or Triamcinolone may be tried if it fails to reduce oedema
  • 5. DMO with PDR: Inj Ranibizumab or Aflibercept followed by PRP. Note: PRP is done in 2-3 sittings to get rid of exerbation of macular oedema.
  • 6. PDR without DMO: PRP in 2-3 sittings Note: Alternatively Inj Ranibizumab or Aflibercept may be given. Inj Bevacizumab is not that effective.
  • 7. Indications of Surgery in Diabetic Retinopaty: Resistant cases, particularly if VMT or ERM is present ADED